Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-06-28FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUMET (sitagliptin and metformin hydrochloride) filed by Merck Sharp & Dohme LLC.
-
FDA approval · 2013-06-27FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOS (pioglitazone) from Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2013-06-26FDA Approved: ALOGLIPTIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved a supplemental application for alogliptin submitted by Padagis Israel Pharmaceuticals Ltd.
-
FDA approval · 2013-06-18FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JENTADUETO (linagliptin and metformin hydrochloride) from Boehringer Ingelheim Pharmaceutica…
-
FDA approval · 2013-06-18FDA Approved: TRADJENTA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Tradjenta (linagliptin) from Boehringer Ingelheim Pharmaceuticals, Inc. The approval updates the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-06-12FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Eli Lilly's insulin lispro product, updating regulatory status for the approved formulation. Thi…
-
FDA approval · 2013-06-05FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for Lantus SoloStar (insulin glargine) by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2013-05-31FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) by Eli Lilly and Company.
-
FDA approval · 2013-05-30FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company. The action authorizes changes to the produ…
-
FDA approval · 2013-05-30FDA Approved: ALOGLIPTIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for alogliptin submitted by Padagis Israel Pharmaceuticals Ltd.
-
FDA approval · 2013-05-16FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for Lantus SoloStar (insulin glargine) by Sanofi U.S. LLC.
-
FDA approval · 2013-05-13FDA Approved: ACARBOSE — Supplemental Application (Chartwell RX, LLC)
FDA approves a supplemental application for acarbose (generic) filed by Chartwell RX, LLC under ANDA 202271.
-
FDA approval · 2013-05-10FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin 70/30 (insulin human) submitted by Eli Lilly and Company. The action approves changes un…
-
FDA approval · 2013-05-10FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro (Humalog) from Eli Lilly, marking an update to the product under the existing…
-
FDA approval · 2013-05-10FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin R (insulin human) by Eli Lilly and Company.
-
FDA approval · 2013-04-22FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2013-04-17FDA Approved: GLIMEPIRIDE — Original Application (Florida Pharmaceutical Products, LLC)
The FDA approved an Original Application for a generic version of glimepiride by Florida Pharmaceutical Products, LLC. The approval enables …
-
FDA approval · 2013-04-10FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
FDA approval · 2013-04-10FDA Approved: JANUMET XR — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a Supplemental Application for JANUMET XR (sitagliptin and metformin hydrochloride) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2013-03-29FDA Approved: INVOKANA — Original Application (Janssen Pharmaceuticals, Inc.)
FDA approved INVOKANA (canagliflozin) through its original application, establishing this drug as a novel therapy for adults with type 2 dia…
-
FDA approval · 2013-03-28FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro submitted by Eli Lilly and Company.
-
FDA approval · 2013-03-28FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly and Company. The action concerns the su…
-
FDA approval · 2013-03-27FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine), a pen formulation, filed by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2013-03-14FDA Approved: CYCLOSET — Supplemental Application (Avvisto Therapeutics LLC)
FDA approved a supplemental application for CYCLOSET (bromocriptine mesylate) from Avvisto Therapeutics LLC.
-
FDA approval · 2013-03-14FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly and Company. The notice indicates a supplemental approval rela…